September 2, 2009
Abbott to Acquire Visiogen, Expanding Vision Care Portfolio
Provides Abbott with Next-Generation Cataract Technology to Address Presbyopia

April 27, 2009
Visiogen Secures $40 Million in Equity Financing
Funds Will Support Global Commercialization of the Synchrony® Dual Optic Accommodating Intraocular Lens

April 14, 2009
Synchrony® Accommodating IOL Featured in Ten Podium Presentations at Annual Meeting of the American Society of Cataract and Refractive Surgeons
Clinical research outcomes of the Synchrony® dual optic accommodating intraocular lens (IOL) were featured in ten podium presentations, two posters, and one film at the annual meeting of the American Society of Cataract and Refractive Surgeons (ASCRS).

February 17, 2009
Visiogen Announces Formation of European Subsidiary, Commencement of Controlled Commercial Release of Synchrony® Accommodating IOL
Multiple Scientific Presentations on Synchrony Lens, Expansion of New Clinical Sites Signals New Phase in Company Strategy

December 2, 2008
Visiogen Appoints Seasoned Executive as Chief Financial Officer
Appointment of Mitch C. Hill Signals Accelerating Momentum towards Commercialization of Synchrony Accommodating IOL

November 18, 2008
Clinical Presentations on Synchrony® IOL Receive Top Honors at Annual Meeting of American Academy of Ophthalmology
Patient Outcomes Suggest Physiologic Design and Unique Mechanism of Action Providing True Accommodation

October 8, 2008
Randomized, Controlled, Double-Masked Clinical Trial of Synchrony® Accommodating IOL
Promising Results Presented at 2008 Congress of the European Society of Cataract and Refractive Surgeons

May 14, 2008
Visiogen Appoints Kevin Hykes as Chief Commercial Officer

March 19, 2008
Visiogen’s Interactive Website Wins Golden Advocate Award
Company wins Gold in the Category of Website Design

November 7, 2007
Visiogen Achieves Full Enrollment of Synchrony® Subjects in its Phase III Clinical Trial
Study Examining the Efficacy of the Synchrony 3-Dimensional Dual Optic Accommodating Intraocular Lens Has Reached Critical Recruitment Goal

October 24, 2007
Visiogen, Inc. Launches New Website
New Interactive Educational Website is the Online Home of the Synchrony® 3-Dimensional Dual Optic Accommodating Intraocular Lens

May 17, 2007
Visiogen, Inc. Recognized at American Society of Cataract and Refractive Surgery Symposium with Two Best of Session Papers
Findings Further Support the Validity of the Synchrony® Dual Optic Accommodating Intraocular Lens

February 28, 2007
Visiogen, Inc. Signs Significant Financing Agreement
Company Raises $24 Million, Further Supporting its Mission and the Validity of the Synchrony® Dual Optic Accommodating Intraocular Lens.

January 17, 2007
Visiogen, Inc. Receives FDA Approval to Expand its U.S. Clinical Trial
Expansion of Trial Will Allow Researchers to Further Validate Safety and Effectiveness of the Investigational Synchrony® Dual Optic Accommodating Intraocular Lens.

December 4, 2006
Presentations at American Academy of Ophthalmology Annual Meeting
Feature Visiogen, Inc.—Favorable Reviews by Industry Clinicians Further Endorse Viability of Visiogen’s Synchrony®.

October 18, 2006
Encouraging Clinical Data on Visiogen’s Synchrony® Dual Optic IOL Presented at European Eye Care Conference
Strong Reception at Prestigious European Congress Bodes Well for Visiogen’s Synchrony®

July 10, 2006
Visiogen’s Barbara Niksch to Serve as Industry Representative
on the FDA’s Ophthalmic Devices Panel of the Medical Devices Advisory Committee

June 23, 2006
Visiogen, Inc. Receives European CE Mark For Its Dual-Optic Accommodating Intraocular Lens
Visiogen, Inc. of Irvine, California, today announced that it has received approval in Europe for its dual-optic accommodating intraocular lens (AIOL).